Jump to content

Robert A. Bradway

Edit links
From Wikipedia, the free encyclopedia
Robert A. Bradway
Born1962 or 1963 (age 61–62)
NationalityAmerican
Alma materAmherst College
Harvard University
Occupation(s)Chairman and Chief Executive Officer of Amgen

Robert A. Bradway (born 1962 or 1963)[1] is an American businessman. He is the chairman and chief executive officer of Amgen.[2]

Education

[edit]

Bradway holds a B.S. degree in biology from Amherst College and an MBA from Harvard University.[3]

Career

[edit]

Bradway joined Morgan Stanley in New York in 1985 as a health care industry investment banker. In 1990 he moved to London, where he was a managing director with responsibility for the firm's banking department and corporate finance activities in Europe.[4][5]

Bradway joined Amgen in 2006 as vice president of operations strategy, and was executive vice president and chief financial officer from April 2007 to May 2010.[6] He was its president and chief operating officer from May 2010 to May 2012.[7] In October 2011, he was appointed to the Amgen board of directors. Bradway was named CEO of Amgen in May 2012, and chairman of the board in January 2013.[5]

During Bradway’s tenure as CEO, Amgen's annual revenue increased from $17.3 billion in 2012[8] to $26 billion in 2021,[9] and annual R&D investment increased to $4.2 billion in 2020.[10] Bradway oversaw the acquisition of Iceland-based DeCODE Genetics in 2012,[11] Onyx Pharmaceuticals in 2013,[12] and a 20.5% equity stake in Beijing-based BeiGene in 2020.[13]

Boards and volunteer activities

[edit]

Bradway is on the board of directors of Boeing.[14] He gave the 2016 commencement speech at the Keck Graduate Institute, which is part of The Claremont Colleges.[15] He gave the 2017 commencement speech at the UCLA Anderson School of Management, where he is on the board of trustees and on the board of the Leonard D. Schaeffer Center for Health Policy and Economics.[16]

He is the chairman of the CEO Roundtable on Cancer and a member of the American Heart Association CEO Roundtable.[17]

Public statements

[edit]

Bradway was a keynote speaker at the 2015 World Medical Innovation Forum.[18] In June 2017, he gave the keynote address at the commencement ceremony for graduates of the University of California, Los Angeles Anderson School of Management.[19] Bradway was a speaker at Fortune magazine's Brainstorm Health virtual conference in June 2020.[20][21]

Following the 2020 murder of George Floyd in May 2020, Bradway issued a statement condemning the murder as "senseless" and pledging to address racial inequality at Amgen, stating, "Let's take inspiration from science and trust that progress, like knowledge, builds upon itself, incrementally improving on what exists today until the cumulative adds up to something profound."[22]

On October 1, 2020, Bradway testified before the House Oversight Committee and was questioned by Rep. Katie Porter (D. Cal) for his considerable compensation. He and four other top Amgen executives earned a combined $124.2 million over a three-year period spanning 2017–2019.[23]

References

[edit]
  1. ^ Pollack, Andrew (December 15, 2011). "2 Executives at Amgen Plan to Retire". The New York Times.
  2. ^ On the Call: Amgen CEO Bob Bradway - Yahoo Finance
  3. ^ Amgen – About Amgen – Leadership Team
  4. ^ Robert Bradway: Executive Profile & Biography - Businessweek
  5. ^ a b "Robert A. Bradway". Amgen. Retrieved 13 April 2021.
  6. ^ "Robert Bradway – Forbes". Forbes. Archived from the original on 8 June 2014. Retrieved 19 June 2014.
  7. ^ Amgen CEO Robert Bradway named USC trustee | Press Room | USC
  8. ^ "Amgen Fourth Quarter Profits Drop, Revenue Up for 2012". Kidney News. Vol. 5, no. 3. 1 March 2013. p. 17. Retrieved 3 June 2022.
  9. ^ Dunleavy, Kevin (8 February 2022). "Amgen talks long-term growth, but doubts remain for analysts, investors". Fierce Pharma. Retrieved 3 June 2022.
  10. ^ Mikulic, Matej. "Amgen R&D expenditure 2006-2021". Statista. Retrieved 31 May 2022.
  11. ^ "Amgen Buys deCODE Genetics for $415M". Genetic Engineering and Biotechnology News. 10 December 2012. Retrieved 31 May 2022.
  12. ^ Mukherjee. "Amgen acquires Onyx Pharmaceuticals for $10.4bn". Pharmaceutical Technology.
  13. ^ Taylor, Nick Paul (1 November 2019). "Amgen pays $2.7B to enlist BeiGene as Chinese R&D partner". Fierce Biotech. Retrieved 31 May 2022.
  14. ^ "Leadership". Amgen, Inc. Retrieved 2020-03-12.
  15. ^ "Robert A. Bradway, chairman and chief executive officer at Amgen to be the 2016 Commencement Speaker". Keck Graduate Institute. Retrieved 2018-01-24.
  16. ^ "Amgen CEO Robert A. Bradway to Deliver Commencement Address at UCLA Anderson". UCLA Anderson School of Management. May 8, 2017. Retrieved June 29, 2017.
  17. ^ "Leadership Team". CEO Roundtable on Cancer. Retrieved 2020-05-13.
  18. ^ McDonald, Casey (30 April 2015). "Biogen CEO Highlights Neuroscience Innovation Forum". PharmExec.
  19. ^ Schmitt, Jeff (24 April 2017). "Here's Who The Class Of 2017 Will Hear At Commencement". Poets&Quants.
  20. ^ Pressman, Aaron (7 July 2020). "Amgen CEO is 'optimistic' about COVID-19 clinical trials". Fortune. Retrieved 31 May 2022.
  21. ^ Nusca, Andrew (10 July 2020). "What you missed at Fortune Brainstorm Health 2020". Fortune. Retrieved 31 May 2022.
  22. ^ Leuty, Ron (1 June 2020). "'Eyes can no longer be closed': CEOs speak as racial unrest spreads". San Francisco Business Times. Retrieved 31 May 2022.
  23. ^ "Rep. Katie Porter (D-CA) asks Amgen CEO Robert Bradway why he deserves his salary". The Recount. October 2020. Retrieved 2020-10-01.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Robert_A._Bradway&oldid=1263362591"